Larson Financial Group’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6K Buy
374
+9
+2% +$324 ﹤0.01% 2111
2026
Q1
$11.7K Buy
365
+4
+1% +$142 ﹤0.01% 2138
2025
Q4
$13K Buy
+361
New +$13.3K ﹤0.01% 1967
2025
Q3
Sell
-244
Closed -$10.4K 3654
2025
Q2
$10.4K Buy
244
+12
+5% +$499 ﹤0.01% 1794
2025
Q1
$10.4K Buy
232
+229
+7,633% +$12.3K ﹤0.01% 1627
2024
Q4
$165 Hold
3
﹤0.01% 2499
2024
Q3
$127 Hold
3
﹤0.01% 2492
2024
Q2
$138 Buy
+3
New +$141 ﹤0.01% 2179

Other funds holding VCEL

Larson Financial Group's VCEL Position: Q2 2026 in Review

Larson Financial Group increased its Vericel Corp (VCEL) stake by 2.5% in Q2 2026, buying an estimated $324 and bringing the position to 374 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Larson Financial Group first reported a position in VCEL in Q2 2024 and has held it in 8 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Larson Financial Group held 374 shares of Vericel Corp worth $16.6K as of Q2 2026.
  • Larson Financial Group bought 9 Vericel Corp shares in Q2 2026, an estimated $324.
  • Vericel Corp made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2111 holding.
  • Larson Financial Group first reported a position in Vericel Corp in Q2 2024 and has held it in 8 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.